Goodwin v. Commissioner of Social Security

CourtDistrict Court, E.D. New York
DecidedSeptember 30, 2022
Docket2:20-cv-02775
StatusUnknown

This text of Goodwin v. Commissioner of Social Security (Goodwin v. Commissioner of Social Security) is published on Counsel Stack Legal Research, covering District Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Goodwin v. Commissioner of Social Security, (E.D.N.Y. 2022).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK -------------------------------------------------------------------X CHRISTINA M. GOODWIN, For Online Publication Only Plaintiff, ORDER -against- 20-CV-02775 (JMA)

COMMISSIONER OF SOCIAL SECURITY, FILED Defendant. CLERK -------------------------------------------------------------------X 12:48 pm, Se p 30, 2022

APPEARANCES U.S. DISTRICT COURT Daniel A. Osborn, Esq EASTERN DISTRICT OF NEW YORK LONG ISLAND OFFICE 43 West 43rd St, Suite 131 New York, New York 10036 Attorney for Plaintiff

Scott C. Akerman, Esq. Social Security Administration 601 East 12th St., Room 965 Kansas City, Mo 641106 Attorney for Defendant

AZRACK, United States District Judge: Plaintiff Christina M. Goodwin (“Plaintiff” or “Goodwin”) seeks review of the final administrative decision by the Commissioner of Social Security (the “Commissioner”), reached after a hearing before an administrative law judge (“ALJ”), denying her application for disability benefits under Title II of the Social Security Act (the “Act”). Before the Court are the parties’ cross-motions for judgment on the pleadings. (ECF Nos. 18, 20.) Because the Court finds that the ALJ failed to comply with the treating physician rule, Plaintiff’s motion for judgment on the pleadings is GRANTED and the Commissioner’s cross-motion is DENIED. I. BACKGROUND A. Procedural History Plaintiff filed her application for Title II Supplemental Security Income (“SSI”) benefits on July 8, 2016, alleging a disability onset date of September 11, 2015 due to multiple sclerosis,

fatigue, balance impairment and cognitive impairment. (Tr. 22, 24-25, 194; see also ECF No. 1, Complaint (“Compl.”)).1 Following the denial of her application on October 17, 2016 (Tr. 22), Plaintiff requested a hearing and was represented by counsel at an administrative hearing on April 9, 2019 before administrative law judge Andrew S. Weiss (“ALJ Weiss”). (Tr. 92-126.) The ALJ issued an unfavorable decision on May 3, 2019, finding Plaintiff not disabled during the period between September 11, 2015, her alleged onset date, and December 31, 2018, the date she had to establish disability to be entitled to benefits under Title II of the Act. (Tr. 22-33.) B. Factual Background Plaintiff was born in 1981 and was thirty-four (34) years old at the time of the onset of her

alleged disability. (Tr. 158.) She has completed some college and previously worked as a receptionist. (Tr. 95-96.) C. Relevant Medical Evidence Plaintiff was treated by Dr. Saud Sadiq (“Dr. Sadiq”), a multiple sclerosis (or “MS”) 1 specialist, from April 30, 2012 through June 2019. (Tr. 11, 481.) On August 20, 2016, Dr. Sadiq submitted a medical source statement. (Tr. 399-402.) The statement explained that he first began treating Plaintiff in April 2012. (Tr. 399.) Dr. Sadiq listed Plaintiff’s diagnosis as multiple sclerosis and identified her symptoms as bladder problems,

1 “Tr.” refers to the correspondingly numbered page in the certified administrative record. chronic fatigue, and decreased cognitive abilities. (Tr. 399.) The statement noted that Plaintiff’s cranial nerves were normal, her deep tendon reflexes were normal, her strength was normal, and her grip strength, rapid alternating movements, and fine manipulation were normal. (Tr. 400.) There were no abnormal movements. (Tr. 400.) Dr. Sadiq also opined that Plaintiff would have

no limitation in terms of lifting or carrying, would have no limitation pushing or pulling, could stand and walk up to six hours a day, and would have no sitting limitation. (Tr. 401.) At a December 19, 2016 visit, Plaintiff reported to Dr. Sadiq that she had two more falls. (Tr. 449.) She also reported blurry vision but denied eye pain. (Tr. 449.) She also reported tingling in her extremities. (Tr. 449.) Plaintiff described fatigue but said that Adderall “sometimes” helped for fatigue. (Tr. 449.) At an August 24, 2017 visit, Plaintiff reported to Dr. Sadiq that she had gastrointestinal issues and esophagitis. (Tr. 451.) The record indicates that Plaintiff’s medications were “on hold” because she expected to get pregnant. (Tr. 451.) An MRI of Plaintiff’s thoracic spine taken on December 18, 2016 revealed “no cord demyelination.” (Tr. 466.) A December 9, 2016 MRI of

her cervical spine revealed a “single C3 level demyelinating cord plaque.” (Tr. 464.) On February 25, 2019, Dr. Sadiq completed another medical source statement regarding Plaintiff’s physical limitations. (Tr. 481.) He again reported that he first treated Plaintiff in April 2012 and had continued to treat her through July 2018. (Tr. 481.) Dr. Sadiq listed Plaintiff’s symptoms as reduced strength, numbness/tingling, migraines, unstable walking, bladder problems, fatigue, and decreased attention/concentration. (Tr. 481.) Regarding her physical limitations, Dr. Sadiq opined that Plaintiff could sit for 6 hours and stand/walk for 3-4 hours, but in addition to regular scheduled breaks, she would require rest and/or unscheduled breaks during the workday. (Tr. 482.) Dr. Sadiq further opined that Plaintiff could tolerate moderate stress but that stress exacerbates her symptoms, and that Plaintiff would be unable to meet strict deadlines, complete detailed or complicated tasks, tolerate heights or moving machinery and handle fast paced tasks. (Tr. 483.) Dr. Sadiq stated that due to Plaintiff’s condition he could not predict how often she would need to be absent from work. (Tr. 483.)

On March 4, 2019, Dr. Sadiq advised that: [Plaintiff] has been a patient under my care for the treatment of multiple sclerosis (MS) since April 2012. One of [Plaintiff]’s most disabling symptoms due to this disease is pathological fatigue. MS fatigue is unable to be measured, but as an MS specialist who has treated thousands of MS patients, I can attest that fatigue due to MS is debilitating and unable to be treated effectively in many cases. Fatigue is one of the most common symptoms of MS, occurring in a large percentage of the patient population. It can significantly interfere with a person’s ability to function at home and work, and is one of the primary causes of early departure from the workforce. Fatigue may be the most prominent symptom in a person who otherwise has minimal activity limitations. (Tr. 484.) At the April 9, 2019 hearing, Plaintiff testified that she was first diagnosed with MS in January 2009. (Tr. 97-98.) Due to MS, she has lesions on her cervical spine and throughout her brain. (Tr. 101-102.) Plaintiff testified that she has balance problems and severe fatigue, which requires frequent rest breaks, and that she experiences difficulty concentrating and remembering. (Tr. 101-102.) Her doctor prescribed Ampyr, a muscle strengthener, which has provided a slight improvement in her gait. (Tr. 105.) Plaintiff was prescribed other medications, Ocrevus and Rituxan, but discontinued them after they caused her to have upper respiratory infections and other side effects. (Tr. 108.) On June 27, 2019, Dr. Sadiq submitted an additional letter, opining on Plaintiff’s condition and limitations: “Christina requires frequent breaks to rest throughout the day due to her MS fatigue. In the event she is unable to rest during the day, it is necessary for her to use the entire day following to recover. Her fatigue has impacted her ability to function efficiently on a daily basis, and prevents her from adhering to a normal or restricted work schedule.” (Tr. 11.) II. DISCUSSION A. Social Security Disability Standard Under the Act, “disability” is defined as “inability to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected to last for a continuous period of not less than 12 months.” 42 U.S.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Burgess v. Astrue
537 F.3d 117 (Second Circuit, 2008)
Richardson v. Perales
402 U.S. 389 (Supreme Court, 1971)
Robert M. Wilson v. Commissioner of Social Security
378 F.3d 541 (Sixth Circuit, 2004)
Poupore v. Astrue
566 F.3d 303 (Second Circuit, 2009)
Moscatiello v. Apfel
129 F. Supp. 2d 481 (E.D. New York, 2001)
Dailey v. Barnhart
277 F. Supp. 2d 226 (W.D. New York, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
Goodwin v. Commissioner of Social Security, Counsel Stack Legal Research, https://law.counselstack.com/opinion/goodwin-v-commissioner-of-social-security-nyed-2022.